SLC23A2 and ischemia: The results demonstrated that SVCT2 overexpression using AAV-SVCT2 (Supplementary Figure 1A) benefited functional recovery (Figure 3A) and decreased infarct volume on day 7 post-ischemia than that in MACO group (Figures 3B,C).